Literature DB >> 33642057

Cerebrovascular events during pregnancy and puerperium.

M Yger1, D Weisenburger-Lile2, S Alamowitch3.   

Abstract

Though cerebrovascular complications of pregnancy remain relatively rare, they represent a potentially devastating event that necessitates prompt identification and treatment. Eighteen percent of strokes occurring in young women are linked to pregnancy. They occur mostly in the third trimester or during the post-partum period. Their biggest risk factors are hypertension, preeclampsia/eclampsia and migraine. Cerebrovascular events occurring during this period may involve specific pathophysiological processes that include embolic phenomena or endothelial dysfunction, but can also have common etiologies that are simply favored by the context of pregnancy. Thus, posterior encephalopathy and vasoconstriction cerebral syndrome are relatively frequently involved in cerebrovascular complications of pregnancy. Other very specific causes like amniotic fluid embolism or postpartum cardiomyopathy can also be responsible for such events. The management of stroke during pregnancy must be multidisciplinary and include a neurovascular expertise. Some conditions can lead to a long-life follow-up and modify the management of a future pregnancy.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Endothelial dysfunction; Migraine; PRES; Preeclampsia; Pregnancy; RCVS; Stroke

Mesh:

Year:  2021        PMID: 33642057     DOI: 10.1016/j.neurol.2021.02.001

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  1 in total

1.  Incidence and Time Trends of Pregnancy-Related Stroke Between 2010 and 2018: The Nationwide CONCEPTION Study.

Authors:  Alice Martin; Grégory Lailler; Yannick Béjot; Amélie Gabet; Clémence Grave; Nolwenn Regnault; Edouard Chatignoux; Elodie Moutengou; Catherine Deneux-Tharaux; Sandrine Kretz; Claire Mounier-Vehier; Vassilis Tsatsaris; Genevieve Plu-Bureau; Jacques Blacher; Valérie Olié
Journal:  Neurology       Date:  2022-08-29       Impact factor: 11.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.